| Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia |
Globe Newswire |
04/12 |
19:30 |
| Kornit Digital Acquires PrintFactory to Accelerate the Industry’s Transition to Digital, On-Demand Production |
Globe Newswire |
04/12 |
18:00 |
| Kornit Digital Brings Global Apparel Leaders Together to Accelerate the Move Towards On-Demand Production |
Globe Newswire |
04/12 |
18:00 |
| Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026 |
Globe Newswire |
04/12 |
18:00 |
| UniX AI Claims First Real-Home Deployment of Mass-Produced Humanoid Robot Panther |
Globe Newswire |
04/11 |
21:23 |
| Trillion Dollar Robot Under Investigation: New 2026 Report Highlights Nvidia AI Expansion, Autonomous Trucking Breakthroughs, and Rapid Expansion of Robotics Infrastructure |
Globe Newswire |
04/11 |
18:02 |
| AI's Second Wind Is Here — Weiss Ratings Plus Report Cites 303% Historical Average and 2026 Data Signals Pointing Beyond the First AI Cycle |
Globe Newswire |
04/11 |
17:45 |
| CSGORoll Casino Aims Best CSGO Gambling Site 2026 |
Globe Newswire |
04/11 |
16:24 |
| Safe Money Report Claims Evaluated: Health Bomb Analysis by Weiss Ratings Examines Healthcare Cost Pressures, Defensive Investment Strategies, and Economic Risk Factors for 2026 |
Globe Newswire |
04/11 |
15:54 |
| Gelatine Sculpt Unveiled: Does This Pink Gelatin Trick for Weight Loss Legit? Read Gelatine Sculpt Report! |
Globe Newswire |
04/11 |
15:09 |
| Bitcoin Casino No Deposit Bonus 2026: BitStarz Launches 50 Free Spins No Deposit Bonus with Instant Withdrawals |
Globe Newswire |
04/11 |
14:44 |
| BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer |
Globe Newswire |
04/11 |
07:00 |
| City Furniture and GARVEE Explore Omnichannel Retail Collaboration in North America |
Globe Newswire |
04/11 |
06:00 |
| NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification |
Globe Newswire |
04/10 |
23:29 |
| Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services Portfolio |
Globe Newswire |
04/10 |
23:26 |
| Pulsetto Claims Evaluated: 2026 Update on the Pulsetto Vagus Nerve Stimulator, Features, Pricing, and Consumer Use Considerations |
Globe Newswire |
04/10 |
22:53 |
| Emma Relief Claims Evaluated: Rising Consumer Interest in Gut Health Formulas for Bloating and Digestive Support in 2026 |
Globe Newswire |
04/10 |
21:13 |
| Sandisk Corporation to Join the Nasdaq-100 Index® Beginning April 20, 2026 |
Globe Newswire |
04/10 |
20:00 |
| Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas |
Globe Newswire |
04/10 |
19:12 |
| IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information |
Globe Newswire |
04/10 |
18:54 |
| INVESTOR NOTICE: Eos Energy (EOSE) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/10 |
18:15 |
| ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility |
Globe Newswire |
04/10 |
17:13 |
| JIADE LIMITED Announces Fiscal Year 2025 Financial Results |
Globe Newswire |
04/10 |
17:00 |
| GSIT Investor News: If You Have Suffered Losses in GSI Technology Inc. (NASDAQ: GSIT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
04/10 |
16:53 |
| Arqit Quantum Inc. Announces Select Preliminary Financial Results for the First Half of Fiscal Year 2026 |
Globe Newswire |
04/10 |
16:30 |
